ARimidex Therapy Compliance Electronic MonitorIng System. A Study to Evaluate the Impact of Educational Material on the Adherence to Treatment With Adjuvant Anastrozole for Postmenopausal Women With Hormone Sensitive Early Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 13 Feb 2012
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms ARTEMIS
- Sponsors AstraZeneca
- 13 Feb 2012 Actual patient number changed from 107 to 104 as reported by ClinicalTrials.gov.
- 01 Sep 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.